Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jun 02 2025

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jun-02-2025-1

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated Jun 02, 2025, titled "Zydus receives tentative approval from the USFDA for Rifaximin Tablets 550mg".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases